Misbehaving macrophages in the pathogenesis of psoriasis
- PMID: 16886055
- PMCID: PMC1523394
- DOI: 10.1172/JCI29441
Misbehaving macrophages in the pathogenesis of psoriasis
Abstract
Psoriasis is a chronic inflammatory skin disease unique to humans. In this issue of the JCI, 2 studies of very different mouse models of psoriasis both report that macrophages play a key role in inducing psoriasis-like skin disease. Psoriasis is clearly a polygenic, inherited disease of uncontrolled cutaneous inflammation. The debate that currently rages in the field is whether psoriasis is a disease of autoreactive T cells or whether it reflects an intrinsic defect within the skin--or both. However, these questions have proven difficult to dissect using molecular genetic tools. In the current studies, the authors have used 2 different animal models to address the role of macrophages in disease pathogenesis: Wang et al. use a mouse model in which inflammation is T cell dependent, whereas the model used by Stratis et al. is T cell independent (see the related articles beginning on pages 2105 and 2094, respectively). Strikingly, both groups report an important contribution by macrophages, implying that macrophages can contribute to both epithelial-based and T cell-mediated pathways of inflammation.
Figures
Comment in
-
Re: misbehaving macrophages in the pathogenesis of psoriasis. Response to Clark and Kupper.J Clin Invest. 2006 Dec;116(12):3088; author reply 3088-9. doi: 10.1172/JCI30698. J Clin Invest. 2006. PMID: 17143321 Free PMC article. No abstract available.
Comment on
-
Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation.J Clin Invest. 2006 Aug;116(8):2094-104. doi: 10.1172/JCI27179. J Clin Invest. 2006. PMID: 16886058 Free PMC article.
-
Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation.J Clin Invest. 2006 Aug;116(8):2105-14. doi: 10.1172/JCI27180. J Clin Invest. 2006. PMID: 16886059 Free PMC article.
References
-
- Olsen E., et al. Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J. Clin. Oncol. 2001;19:376–388. - PubMed
-
- Prinz J.C. The role of T cells in psoriasis. . J. Eur. Acad. Dermatol. Venereol. 2003;17:257–270. - PubMed
-
- Sano S., et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med. 2005;11:43–49. - PubMed
Publication types
MeSH terms
Grants and funding
- P30 AR-42689-11/AR/NIAMS NIH HHS/United States
- R37 AI-25082-17/AI/NIAID NIH HHS/United States
- 1U19 AI57330-01/AI/NIAID NIH HHS/United States
- R37 AI025082/AI/NIAID NIH HHS/United States
- P50 CA093683/CA/NCI NIH HHS/United States
- U19 AI057330/AI/NIAID NIH HHS/United States
- R01 AI-41707-09/AI/NIAID NIH HHS/United States
- 1K08AI060890-01A1/AI/NIAID NIH HHS/United States
- P30 AR042689/AR/NIAMS NIH HHS/United States
- HHSN266200400030C/PHS HHS/United States
- K08 AI060890/AI/NIAID NIH HHS/United States
- P50 CA-93683-04/CA/NCI NIH HHS/United States
- R01 AI041707/AI/NIAID NIH HHS/United States
- HHSN266200400030C/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
